SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-015358
Filing Date
2024-04-19
Accepted
2024-04-19 16:50:28
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 874906
2 ex10-83.htm EX-10.83 50910
3 ex31-1.htm EX-31.1 22694
4 ex32-1.htm EX-32.1 11002
  Complete submission text file 0001493152-24-015358.txt   5561432

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bixt-20240331.xsd EX-101.SCH 49805
6 XBRL CALCULATION FILE bixt-20240331_cal.xml EX-101.CAL 42701
7 XBRL DEFINITION FILE bixt-20240331_def.xml EX-101.DEF 254693
8 XBRL LABEL FILE bixt-20240331_lab.xml EX-101.LAB 370128
9 XBRL PRESENTATION FILE bixt-20240331_pre.xml EX-101.PRE 329271
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 768614
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 24858492
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)